Brain Injury 2018

Welcome Message

Welcome Message from the Committee

It is such a great honor to be part the Organizing Committee of this prestigious event and I would like to welcome everyone to Brain Injury 2018.

With this year’s theme: “Explore the Latest Innovative Treatment and Prevention of Brain Injury”, we are very much excited in imparting to everyone our thought provoking program for this conference. We all aim for continuous improvement and maintain the high level of expertise, scientific knowledge and training programs using the latest innovations and treatment available worldwide. We are hoping that through this conference we can inspire and motivate everyone to explore more in innovative and modernized treatment.

Sessions/Tracks

Brain disorders are one of the most serious health problems facing our society .Brain disorders or Brain damage includes many conditions that can affect your brain. Those conditions that are caused by illness, genetics, or brain injury.

When the brain is damaged, it can affect many different things, such as memory, sensation, and functions. The brain is susceptible to different disorders that strike at every stage of our life. They are also the most mysterious of all diseases.

Dementia is a chronic and higher intellectual function due to organic brain disease. Dementia is condition in which a person loses their ability to think, remember, learn, and to make decisions, and solve the problems. It may also include like personality changes and emotional problems. Some other problems like decrease in motivation emotional problems and problems with language.

Globally, dementia affected total of 46 million people in 2015.About 10% of people develop this disorder at any some point of their lives.By ages 3% of the people between the ages 65–74 have dementia, and 19% of people between the age 75 and 84 and nearly half of those over 85 years of age. In 2013 dementia was resulted in about 1.7 million deaths in 1990.As more number of people are living longer, dementia is becoming very common in population as a whole. It is to be believed to result in economic costs of 604 billion USD per year.

Based on regions, global neurodegenerative disease market is segmented into the seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Global market for neurodegenerative disease is expected to grow by a CAGR are of around 5%. Asia Pacific is expected to witness the highest growth due to the large population base over the forecast years.

Geriatric and obese population people are at high risk for the developing peripheral neuropathy. Centers for Disease Control and Prevention stated, that the people who are diagnosed with diabetes mostly are obese. so, with the rising in geriatric population and growing prevalence of diabetes propels the demand of global market to peripheral neuropathy treatment. According to World Health Organization, the global geriatric population increase from 524 million in 2010 to about 2 billion by the year 2050. World Health Organization stated in the year 2012 that, more than the 40 million children under the age of 5 were overweight. And it has also estimated that 10% of the world population of adult was obese in 2012.

World Health Organization estimated in the year 2006 that neurological disorders affect one billion people worldwide.

Market of CNS disorders are categorized into three segments, psychiatry,neurology and pain drugs market.. Among these the psychiatry segment has the largest share that accounting for more than 40% next followed by neurology and pain segment. As of year 2012, world health organization said that about 50 million people are suffering from epilepsy worldwide most of them belong to developing nations.

In 2013 about 6.9 million people had an ischemic stroke and about 3.4 million people had a haemorrhagic stroke. In 2015 about 42.4 million people who had previously had a stroke and they were still alive. In between 1990 and 2010 the number of strokes which occurred each year was decreased by 10% in the developed world and increased by approximately 10% in the developing world. After coronary artery disease, death cause by the stroke was in second place in 2015. About half of the people who have had a stroke live less than the one year.

It is a mental disorder, or mental illness. The causes of mental disorders are unknown. Mental disorders are explained by the combination of behaviour of the person , or feels, or thinks. This are associated with the particular regions or functions of the brain.

Globally Some common mental disorders include depression, that affects about 400 million, dementia which affects about 35 million, schizophrenia, that affects about 21 million people . WHO stated that 350 million populations is suffering with depression and mental disorders and approximately 24 million populations globally is affected by schizophrenia disorder. According to the survey conducted by CPA in the year 2012, about 77% of patient population receive psychotherapy are benefited or remained generalized anxiety disorder free after the treatment.

During 2066-2015 as per global report 582 patients were hospitalized with neurological disorders and the ratio of the patients having neuro-CTs raised by 86% to 88%, neuro-MRs by 79%-93%, and requirement of ICU care increased 17% to 26%.

About Conference

On behalf of Conference organizing Committee we would like to officially invite you for 7th International Conference on Brain and Neurological Disorders held during April 10-12, 2018 in Amsterdam, Netherlands

Brain Injury 2018 Conference will give a perfect platform to discuss and sharing the knowledge and ideas on brain injury. These meetings provide an ideal combination of excellent science, an open atmosphere and allowing attendees and speakers to easily focus on academic exchange of ideas.

The main aim of the 7th International Conference on Brain and Neurological Disorders is to provide an opportunity for establishing collegial relationships with the international professionals focused on the science of brain injury research.

Market Analysis

Market analysis:

A neurological disorder has become a growing threat, because of the demographic change and the resulting increase in the elderly populations in Europe. Worldwide there is an over 46 million Alzheimer’s patients and in India over 4 million people are suffering with some type of dementia and the number is estimated to rise to about 131.5 million by 2050.Mental health and research on neuropsychiatric diseases were priorities, with more than EUR 280 million invested since 2007. Brain diseases account for 35% of the overall disease burden and the cost European society almost euro 400 billion per year. Neurological and psychiatric disorders affect a growing number of individuals, nearly, one in five Americans in a year and about two billion people globally.

Each year 600,000 people are newly diagnosed with the neurological condition. 19% of hospital admissions are for the treatment of neurological problem from a neurologist or neurosurgeon mostly for stroke, epilepsy, dementia, and head injury.

The European pharmaceutical industry spent an approximately of €3.3 billion for the brain research per year, corresponding to that 79% of the total funding for brain research in Europe. Research on neuropsychiatric diseases such as depression or schizophrenia has been supported with EUR 283 million. In Europe overall, the neurological damage accounts for the 40% of people who are severely disabled and who are need in daily help. The global neuroscience market size will be reach up to the $30.80 billion by 2020 from $24.09 Billion in 2013, growing at CAGR of 2.9%. The Asia Pacific industry for neuroscience is estimated to grow at a Compound Annual Growth Rate of nearly 3.0% over the forecast period to reach a revenue over USD 8.00 billion by 2020. The global market for the Neuromarketing technology is expected to reach about $22.0 million by 2021, increasing at a compound annual growth rate of 18.0% from 2016 to 2021.

Geographically, neurological disorder drugs market has been segmented into the 10 major regions: Germany, Switzerland, , Italy, Russia,Spain,U.K., Switzerland, Netherlands, France ,Poland and Rest of the Europe. The market for the neurological disorder drugs has been extensively analyzed which is based on their usefulness, effectiveness, sales revenue and also geographic presence. The market size and the forecast in terms of US$ Mn for each disorder, and drug class, distribution channel as well as the geographic regions has been provided for the period of 2016 to 2024. Report on this neurological disorder drugs market also provides the compound annual growth rate (CAGR %) for the each market segment for the forecast period from 2016 to 2024, considering the 2015 as the base year.

Important and scope:

Neurological disorders Is a unique forum to bring worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

The main aim of this conference is to stimulate the new ideas for the treatment that will be beneficial across the spectrum of Neuroscience.

Neurological disorders: This public health challenges describes and discusses about the increasing global public health importance of the common neurological disorders like dementia, epilepsy, headache, multiple sclerosis, and neuroinfections, neurological disorders which are associated with malnutrition, pain associated with the neurological disorders, Parkinson ’s disease, stroke, traumatic brain injuries.

Why Amsterdam, Netherlands:

Amsterdam is the Netherlands’ capital it has a population of about 851,373 within the city proper, and 1,351,587 in the urban area and 2,410,960 in the Amsterdam metropolitan area.

As per the period of 2010–2012, annually 34,681 patients visited the ED due to the TBI, comprising about 4% of the total injury-related ED visits per year in Netherlands. The overall incidence rate of ED visits due to TBI was 213.6 per 100,000 person years, 241.9 for males, 175.3 for females. Incidence rates were highest in children 268.2, young adults 271.6 and older patients 75–84 years 307.6 or 85 and older 578.2. The estimated total costs of TBI in Netherlands was about €314.6 million per year.

Who to attend:

Neurophysiologists, Neurologists, Paediatric Neurologists, Neurosurgeons, physiatrists, Research scientists, Neurology Organizations, and Epileptologists Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Neuroscience foundations, neuroradiologists, Professors, Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and also knowledge in diagnosing and in treating nervous system disorders, social workers.

Conference Highlights:

Brain Disorder

Development Disorders

Dementia

Neurodegenerative disorders

Peripheral Neuropathy

Central Nervous system Disorders

Brain Stroke

Spinal cord disorders

Psychiatric Disorders

Neuro Imaging and Radiology

Brain mapping

Neurosurgery

Neuropharmacology

Neuropathology

Neuroinformatics

Neurotechnology

Neurogenetics

Target Audience:

Academia 60%

Industry 30%

Others 10%

Scope of the Neurological Disorder Drugs Industry on the basis of region:

North America

Europe

China

Japan

Southeast Asia

India

Following are the key players covered in this Neurological Disorder Drugs Market research report:

Novartis AG

GlaxoSmithKline plc

Merck & Co.

Bayer AG

AstraZeneca

Boehringer Ingelheim GmbH

F. Hoffmann-La Roche Ltd.

List of Assciation/Societies around the world:

American Board of Psychiatry and Neurology (ABPN)

American Academy of Neurology (AAN)

American Society of Neuroimaging

American Spinal Injury Association

American Epilepsy Society

American Association of Neurological Surgeons

Child Neurology Society

European Federation of Neurological Societies

National Institute of Neurological Disorders and Stroke

The American Clinical Neurophysiology Society

Indian Academy of Neurology

Neurological Society of India

Alzheimer Europe

American Academy of Neurology

American Academy of Sleep Medicine

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

American Association of Neurological Surgeons

American Autonomic Society

American Epilepsy Society

American Headache Society

American Neurological Association

American Society of Electroneurodiagnostic Technologists

American Society of Neuroimaging

American Synesthesia Association

Associated Professional Sleep Societies

Australasian Stroke Trials Network

Austrian Neurological Association

Belgian Neurological Society

Belgian Society of Pediatric Neurology

Brain Trauma Foundation

British Columbia Society of Electroneurophysiology Technologists

British Paediatric Neurology Association

Cervical Spine Research Society

Cervical Spine Research Society - European Section

Child Neurology Society

Czech Neurological Society

Czech Neuropsychopharmacological Society

Danish Neurological Society

Dutch Society of Neurology

Dystonia Medical Research Foundation

Egyptian Society of Neurology, Psychiatry and Neurosurgery

Euro-Ataxia:

European Charcot Foundation

Neuroscience Research Centers:

Allen Institute

Blanchette Rockefeller Neurosciences Institute

Bernstein Focus: Neurotechnology

CIMIT Neurotechnology Program

Gladstone Institute of Neurological Disease

The Ontario Brain Institute (OBI)

The Van der Veer Institute for Parkinson's and Brain Research

Top Companies:

ACADIA Pharmaceuticals

Accera

Acorda Therapeutics

Agenebio

Alcobra Pharmaceuticals

Anthrotronix

Aptuit

Biogen Idec

Cerecor

ElMindA

Embera NeuroTherapeutics

Forum Pharmaceuticals

Medivation

Microtransponder

Neurocrine Biosciences

Neuronix Medical

NeuroElectrics

NeuroPace

nLife Therapeutics

Photopharmics

Posit Science

Hospitals:

Norfolk and Norwich Hospital

Ipswich Hospital

Lincoln County Hospital

Leicester General Hospital

St Mary's Hospital

Guy's Hospital

St Thomas' Hospital

The Hammersmith Hospital

Sunderland Royal Hospital

Royal Manchester Children's Hospital

Macclesfield District General Hospital

The Great Western Hospital

Poole General Hospital

Musgrove Park Hospital

Royal Devon and Exeter Hospital

Royal Cornwall Hospital

Neurological disorder Market Statistics:

The global market for the neurological disease treatment and medication was worth of $12.6 billion in the year 2006 and it will reach up to the $14 billion by 2007. At a compound annual growth rate 11.6%, the global market will be the worth of almost $24.3 billion by the year 2012.

Drugs for the multiple sclerosis, Alzheimer's disease, and the Parkinson's disease control approximately the 99% of the total market share.

Medications for the multiple sclerosis are just over the 35% greater than market share of medication for the Alzheimer's disease, despite the fact that there are fewer patients with MS. As AD drugs become the more prevalent, the shares of the market could change dramatically.

An estimated of 6.8 million people die every year as a result of neurological disorders. In Europe, the economic cost of the neurological diseases was estimated about the 139 billion euros in the year 2004. Access to appropriate care is difficult for the many people with the neurological disorders, their families and the caregivers. WHO advocates for the integration of neurological care into primary health care. For many people, the primary health care is the only access to the medical care they have. In these settings, the doctors can use low-technology interventions. Community-based rehabilitation is also one of the options.

Past Conference Report

Neurology Congress 2016 Report

8th European Neurology Congress was organized during September 21-23, 2016 at Hyatt Place, Amsterdam, Netherlands. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.

Firstly we must thank you for trusting us and participating at Neurology Congress 2016, a global platform to discuss various important aspects of Neurology and Neuroscience.

There are infinite reasons to extend our gratitude to you for making the Neurology Congress 2016 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Neurology Congress 2016 a new heights in the field of Neurology and Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 50 countries, who have driven this event into the path of success.

The conference was organized around the theme “Exploring the advancements in Neuroscience and Neurology”. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers: Allal Boutajangout, New York University School of Medicine, USA, Giovanni Antioco Putzu, Casa di Cura Sant’Elena, Italy, Peter Silburn, University of Queensland, Australia, Galina Mindlin, Mount Sinai, USA, Mohamed ELSherif, Mansoura University School of Medicine, Egypt, Salvatore Polizzi, Medicina Occupazionale e Ambientale, Italy, David Rowell, Queensland Brain Institute, Australia.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology through their fabulous presentations at the podium of Neurology Congress 2016.

Conferenceseries LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Neurology & Neurophysiology,International Journal of Neurorehabilitation and Journal of Neurological Disorders who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members : Allal Boutajangout, New York University School of Medicine, USA, Giovanni Antioco Putzu, Casa di Cura Sant’Elena, Italy, Amal Al-Hashmi, Royal Hospital Muscat, Oman, Galina Mindlin, Mount Sinai, USA, Saleem I. Abdulrauf, Saint Louis University, USA.

Best Poster Awards (Senior Investigator) honor to Allal Boutajangout, New York University School of Medicine, USA and Best Poster Awards (Young Investigator) honor to Viviane Rostirola Elsner, Biosciences and Rehabilitation of the Methodist University, Brazil and Simone Marcuzzo, Universidade Federal do Rio Grande do Sul, Brazil.

Neuro-2015

OMICS International takes a great pride in announcing the commencement of 4th International Conference and Exhibition on Neurology and Therapeutics-2015 during July 27-29, 2015. Neurology-2015 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Neuroscience. This is one of the extremely distinguished conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities.

The conference was organized around the theme "Novel Therapies in Neurosciences and Neurological Disorders". The event implanted a firm relation of upcoming strategies in the field of Neuroscience with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This annual conference brought together eminent scientists, Neurobiologists, health care professionals, professors of Clinical Neurology and Neuropharmacology, in which many issues in Neural research were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neuroscience. The eminent personalities at the conference were Harish C Pant, National Institute of Health, USA, Jennifer DeFeo, Chicago school of professional psychology, USA, Hamed Benghuzzi, University of Mississippi Medical Center, USA, Alessandro Morelli, University of Genova, Italy.

OMICS International offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Neurology & Neurophysiology, Journal of Brain Disorders & Therapy, Autism-Open Access who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Neuroscience Research. OMICS therefore, is glad to announce its "7th International Conference on Brain and Neurological Disorder" which will be held during April 10-12, 2018 Amsterdam, Netherland.

Neuro-2014

The 3rd International Conference & Exhibition on Neurology and Therapeutics organized by OMICS Group International was successfully held at Hilton Philadelphia Airport, Philadelphia, USA during September 08-10, 2014. The conference was organized with the theme “Novel Therapies in Neurosciences and Neurological Disorders"

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 20 different countries ultimately driving the event into the path of success.

OMICS Group also took the privilege of felicitating Neurology-2014 Organizing Committee, Editorial Board Members of Journal of Neurology & Neurophysiology , Journal of Brain Disorders & Therapy, Journal of Neurological Disorders and Autism- Open Access, Keynote Speakers, Chair and Co-Chairs whose support led the conference into the path of excellence.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

OMICS Group would like to convey a warm gratitude to all the Honorable guests of Neurology-2014. The highlights of the conference were its educative and effectual keynote lectures by:

Simon Kaja, University of Missouri, USA

James Nussbaum, ProHealth & Fitness PT OT, USA

Marie Trad, Quintiles, France

Jacqueline Sidman, The Sidman Institute, USA

All the above mentioned keynote speakers gave their energetic and fruitful contributions at Neurology-2014. All the keynote sessions, speaker sessions, Special session,workshop, symposium, and student poster presentations focused on the specific theme of the conference “Novel Therapies in Neurosciences and Neurological Disorders” The theme of the conference spurred the sessions and provided an insightful and excellent knowledge on the upcoming advances, research, and technology in neurology therapeutics.

On day 2, Jacqueline Sidman conducted a Workshop on “Unravelling defense mechanisms: How the subconscious mind releases early painful memories in order to heal physical, behavioral and emotional problems.” On day 2, Special session on “CNS drug development perspectives for young neurologists” was taken up by Marie Trad, Quintiles, France. Both the workshop and the special session discussed the major breakthroughs and developments in the field of neurology.

On day 3 symposium on “Stem cells for Neurological Disorders” by Guang-Xian Zhang, Thomas Jefferson University, USA discussed the Novel Therapies in Neurology.

The conference also provided an exclusive environment to the students for their development of research and gave them an opportunity to raise the profile of their research by poster presentations. Best poster awards were also given by the student council.

All accepted abstracts have been indexed in Journal of Neurology and Neurophysiology as a special issue.

Neuro-2013
On June 17-19, 2013 OMICS Group hosted the 2nd International Conference and Exhibition on Neurology & Therapeutics in Hilton Chicago/Northbrook, Chicago, USA. OMICS feels proud to present to you the outcome and result of this conference.

All the keynote sessions, other sessions, workshops, symposium, and student poster presentations focused on the specific theme of the conference “Emerging Trends in Neurological Therapeutics.” The theme roofed a broad range of topics including: The Therapeutic Aspects of Molecular and Cellular Neuroscience, Somatic and Autonomic Nervous System, Neurodegenerative and Movement Disorders, Novel Research In Neurological Medicine and Trauma, Application of Computational Neuroscience, Neurological Assessment Systems, Neuro-Oncology, Neurology and Current Research, Nanotechnology and Biomarkers: Future Prospect for Drug Discovery, Case studies of Different Neurological Disorders, Biofeedback and Neuromarketing. The theme of the conference spurred the sessions and provided an insightful and excellent knowledge on the upcoming advances, research, and technology in neurology therapeutics.

Neuro-2012

Neuro-2012 Report

The International Conference & Exhibition on Neurology & Therapeutics, hosted by the OMICS Group was held on May 14-16, 2012 in Embassy Suites Las Vegas, USA. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from neurologists, researchers and leaders from pharma, government organizations who made this conference as one of most successful and productive events in 2012 from OMICS Group.

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

Alzheimer's Disease

Neural Stem Cells and Gene or Cell Therapy

Diagnosis and Genetic Testing for Neurological Disorders

Neuroimmunology

Neuromics & Human Brain proteome

Perspectives in Neurology Research

Neurorehabilitation

Epilepsy

Current trends in Neurophysiology

Cerebral CSF Flow Studies

Diagnosis for cerebral infections

Clinical Neurophysiology & Electrophysiology

The conference was initiated with a series of keynote addresses by well-known speakers Dr. C. David James from University of California, San Francisco, USA, Dr. Asim Mahmoodfrom Henry Ford Hospital, USA, Dr. Ahmad Salehi from Stanford Medical School, USA, Dr. Abha Chauhan from NYS Institute for Basic Research in Developmental Disabilities, USA.

All the above mentioned keynote speakers gave their energetic and fruitful contributions at Neuro-2012.

All accepted abstracts have been indexed in OMICS Group Journal of Neurology & Neurophysiology as a special issue

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Neuro-2012, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference and Exhibition on Neurology & Therapeutics" to be held at Chicago, USA on April 15-17, 2013.

Be a member and support us

Follow us

Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.